FDA approves GSK's Hiberix

FDA granted accelerated approval to a BLA for Hiberix Haemophilus influenzae type B (Hib) vaccine from GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) as a booster dose for children 15 months to four years ol...